{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "30124867",
  "DateCompleted": {
    "Year": "2019",
    "Month": "08",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1093/ijnp/pyy069"
    ],
    "Journal": {
      "ISSN": "1469-5111",
      "JournalIssue": {
        "Volume": "21",
        "Issue": "11",
        "PubDate": {
          "Year": "2018",
          "Month": "Nov",
          "Day": "01"
        }
      },
      "Title": "The international journal of neuropsychopharmacology",
      "ISOAbbreviation": "Int J Neuropsychopharmacol"
    },
    "ArticleTitle": "Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex.",
    "Pagination": {
      "StartPage": "988",
      "EndPage": "996",
      "MedlinePgn": "988-996"
    },
    "Abstract": {
      "AbstractText": [
        "Identification of biomarkers predicting therapeutic outcome of antidepressant treatment is one of the most important tasks in current research because it may transform the lengthy process of finding the right treatment for a given individual with depression. In the current study, we explored the potential of pretreatment pregenual anterior cingulate cortex activity as a putative biomarker of treatment response.",
        "Thirty-two medication-free patients with depression were treated for 6 weeks with a selective serotonin reuptake inhibitor, escitalopram. Before treatment began, patients underwent an fMRI scan testing response to brief, masked, presentations of facial expression depicting sadness and happiness.",
        "After 6 weeks of treatment, there were 20 selective serotonin reuptake inhibitor responders and 12 nonresponders. Increased pretreatment pregenual anterior cingulate cortex activity to sad vs happy faces was observed in responders relative to nonresponders. A leave-one-out analysis suggested that activity in the anterior cingulate cortex was able to predict response status at the level of the individual participant.",
        "The study supports the notion of pregenual anterior cingulate cortex as a promising predictor of antidepressant response."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Psychopharmacology Research Unit, University Department of Psychiatry, University of Oxford, Oxford, United Kingdom."
          },
          {
            "Identifier": [],
            "Affiliation": "Oxford Health NHS Foundation Trust, Warneford Hospital, Warneford Lane, Oxford, United Kingdom."
          }
        ],
        "LastName": "Godlewska",
        "ForeName": "Beata R",
        "Initials": "BR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Oxford Health NHS Foundation Trust, Warneford Hospital, Warneford Lane, Oxford, United Kingdom."
          },
          {
            "Identifier": [],
            "Affiliation": "Computational Psychiatry Lab, University Department of Psychiatry, University of Oxford, Oxford, United Kingdom."
          }
        ],
        "LastName": "Browning",
        "ForeName": "Michael",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychology, Whitelands College, University of Roehampton, London, United Kingdom."
          }
        ],
        "LastName": "Norbury",
        "ForeName": "Ray",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Barnet Enfield and Haringey Mental Health NHS Trust, United Kingdom."
          }
        ],
        "LastName": "Igoumenou",
        "ForeName": "Artemis",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Psychopharmacology Research Unit, University Department of Psychiatry, University of Oxford, Oxford, United Kingdom."
          },
          {
            "Identifier": [],
            "Affiliation": "Oxford Health NHS Foundation Trust, Warneford Hospital, Warneford Lane, Oxford, United Kingdom."
          }
        ],
        "LastName": "Cowen",
        "ForeName": "Philip J",
        "Initials": "PJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Psychopharmacology and Emotion Research Laboratory, University Department of Psychiatry, University of Oxford, Oxford, United Kingdom."
          }
        ],
        "LastName": "Harmer",
        "ForeName": "Catherine J",
        "Initials": "CJ"
      }
    ],
    "GrantList": [
      {
        "GrantID": "MR/K022202/1",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "MR/N008103/1",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      },
      {
        "GrantID": "MR/K022202",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Int J Neuropsychopharmacol",
    "NlmUniqueID": "9815893",
    "ISSNLinking": "1461-1457"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Serotonin Uptake Inhibitors"
    },
    {
      "RegistryNumber": "0DHU5B8D6V",
      "NameOfSubstance": "Citalopram"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Citalopram"
    },
    {
      "QualifierName": [
        "diagnostic imaging",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "diagnostic imaging",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Emotions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Facial Expression"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Facial Recognition"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "diagnostic imaging",
        "physiopathology"
      ],
      "DescriptorName": "Gyrus Cinguli"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Magnetic Resonance Imaging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychiatric Status Rating Scales"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Selective Serotonin Reuptake Inhibitors"
    }
  ]
}